Self-confidence Study in Patients With Argus II Artificial Retina

Overview

To evaluate whether the use of the Argus II retinal prosthesis improves the confidence and self-esteem of patients with advanced retinopathy pigmentosa

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: February 2019

Clinical Trial Outcome Measures

Primary Measures

  • Self-confidence
    • Time Frame: 12 months
    • Evaluation of Self-confidence via a questionnaire

Participating in This Clinical Trial

Inclusion Criteria

  • Major patient (≥18 years old) – Patient already operated in France with artificial retina and having 1 year of follow-up – Patient who has agreed to use his medical data for research purposes Exclusion Criteria:

  • Refusal to participate in the study

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University Hospital, Strasbourg, France
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • David GAUCHER, MD, PhD, Study Director, University Hospital, Strasbourg, France
  • Overall Contact(s)
    • David GAUCHER, MD, PhD, 33 3 69 55 11 15, david.gaucher@chru-strasbourg.fr

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.